GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
2022-04-05 $1.09 $1.13 $1.09 $1.09 777 900
2022-04-04 $1.12 $1.12 $1.07 $1.09 825 800
2022-04-01 $1.08 $1.10 $1.05 $1.07 708 666
2022-03-31 $1.10 $1.16 $1.05 $1.07 1 295 937
2022-03-30 $1.13 $1.15 $1.10 $1.11 956 301
2022-03-29 $1.16 $1.20 $1.12 $1.12 1 651 900
2022-03-28 $1.21 $1.25 $1.14 $1.14 1 036 700
2022-03-25 $1.29 $1.29 $1.20 $1.23 1 008 900
2022-03-24 $1.30 $1.34 $1.25 $1.26 1 027 000
2022-03-23 $1.31 $1.35 $1.29 $1.30 1 116 300
2022-03-22 $1.28 $1.35 $1.25 $1.31 5 504 949
2022-03-21 $1.85 $1.88 $1.78 $1.80 330 830
2022-03-18 $1.83 $1.93 $1.83 $1.88 276 158
2022-03-17 $1.68 $1.87 $1.68 $1.84 185 700
2022-03-16 $1.65 $1.71 $1.64 $1.71 127 500
2022-03-15 $1.64 $1.64 $1.56 $1.62 149 700
2022-03-14 $1.73 $1.75 $1.57 $1.59 231 100
2022-03-11 $1.77 $1.83 $1.72 $1.73 125 900
2022-03-10 $1.75 $1.78 $1.71 $1.78 177 100
2022-03-09 $1.71 $1.85 $1.67 $1.77 410 300
2022-03-08 $1.69 $1.70 $1.59 $1.61 437 700
2022-03-07 $1.71 $1.74 $1.63 $1.67 414 600
2022-03-04 $1.79 $1.83 $1.72 $1.72 223 400
2022-03-03 $1.90 $1.90 $1.76 $1.80 207 600
2022-03-02 $1.99 $1.99 $1.84 $1.86 214 500
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT